1,347
Views
14
CrossRef citations to date
0
Altmetric
Articles

Decreased Risk of COPD Exacerbations in Obese Patients

, , , , , & ORCID Icon show all
Pages 485-491 | Received 04 May 2020, Accepted 18 Jul 2020, Published online: 05 Aug 2020

References

  • Flegal KM , Kit BK , Orpana H , et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82. DOI:10.1001/jama.2012.113905
  • Gruberg L , Weissman NJ , Waksman R , et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39(4):578–584. DOI:10.1016/S0735-1097(01)01802-2
  • Horwich TB , Fonarow GC , Hamilton MA , et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38(3):789–795. DOI:10.1016/S0735-1097(01)01448-6
  • Chittal P , Babu AS , Lavie CJ . Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease?. COPD. 2015;12(1):14–18. DOI:10.3109/15412555.2014.915934
  • Keller K , Hobohm L , Munzel T , et al. Survival benefit of obese patients with pulmonary embolism. Mayo Clin Proc. 2019;94(10):1960–1973. DOI:10.1016/j.mayocp.2019.04.035
  • Cao C , Wang R , Wang J , et al. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One. 2012;7(8):e43892. DOI:10.1371/journal.pone.0043892
  • Guo Y , Zhang T , Wang Z , et al. Body mass index and mortality in chronic obstructive pulmonary disease: a dose-response meta-analysis. Medicine (Baltimore). 2016;95(28):e4225. DOI:10.1097/MD.0000000000004225
  • Divo MJ , Cabrera C , Casanova C , et al. Comorbidity distribution, clinical expression and survival in COPD patients with different body mass index. Chronic Obstr Pulm Dis. 2014;1(2):229–238. DOI:10.15326/jcopdf.1.2.2014.0117
  • Puhan MA , Hansel NN , Sobradillo P , et al. Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open. 2012;2(6):e002152. doi: bmjopen-2012-002152 [pii] DOI:10.1136/bmjopen-2012-002152
  • van Hirtum PV , Sprooten RTM , van Noord JA , et al. Long term survival after admission for COPD exacerbation: a comparison with the general population. Respir Med. 2018;137:77–82. DOI:10.1016/j.rmed.2018.02.015
  • Anzueto A , Miravitlles M . Chronic obstructive pulmonary disease exacerbations: a need for action. Am J Med. 2018;131(9S):15–22. DOI:10.1016/j.amjmed.2018.05.003
  • Burchette JE , Campbell GD , Geraci SA . Preventing hospitalizations from acute exacerbations of chronic obstructive pulmonary disease. Am J Med Sci. 2017;353(1):31–40. DOI:10.1016/j.amjms.2016.06.006
  • Wei YF , Tsai YH , Wang CC , et al. Impact of overweight and obesity on acute exacerbations of COPD - subgroup analysis of the Taiwan Obstructive Lung Disease cohort. Int J Chron Obstruct Pulmon Dis. 2017;12:2723–2729. DOI:10.2147/COPD.S138571
  • Wu Z , Yang D , Ge Z , et al. Body mass index of patients with chronic obstructive pulmonary disease is associated with pulmonary function and exacerbations: a retrospective real world research. J Thorac Dis. 2018;10(8):5086–5099. DOI:10.21037/jtd.2018.08.67
  • Singh D , Agusti A , Anzueto A , et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. DOI:10.1183/13993003.00164-2019
  • Slenter RH , Sprooten RT , Kotz D , et al. Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respiration. 2013;85(1):15–26. DOI:10.1159/000342036
  • Soler-Cataluna JJ , Martinez GM , Roman SP , et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. DOI:10.1136/thx.2005.040527
  • Sprooten RTM , Rohde GGU , Lawyer G , et al. Risk stratification for short-term mortality at hospital admission for acute exacerbations of COPD. Respirology. 2019;24(8):765–776. DOI:10.1111/resp.13538
  • Donaldson GC , Seemungal TA , Bhowmik A , et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. DOI:10.1136/thorax.57.10.847
  • Donaldson GC , Wilkinson TM , Hurst JR , et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(5):446–452. DOI:10.1164/rccm.200408-1054OC
  • Seemungal TA , Donaldson GC , Bhowmik A , et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. DOI:10.1164/ajrccm.161.5.9908022
  • Franssen FM , O'Donnell DE , Goossens GH , et al. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63(12):1110–1117. DOI:10.1136/thx.2007.086827
  • Wedzicha JA . Exacerbations: etiology and pathophysiologic mechanisms. Chest. 2002;121(5 Suppl):136S–141S. DOI:10.1378/chest.121.5_suppl.136s
  • Beeh KM , Burgel PR , Franssen FME , et al. How do dual long-acting bronchodilators prevent exacerbations of chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2017;196(2):139–149. DOI:10.1164/rccm.201609-1794CI
  • Abdulai RM , Jensen TJ , Patel NR , et al. Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(4):433–449. DOI:10.1164/rccm.201703-0615CI
  • Blondeel A , Demeyer H , Janssens W , et al. The role of physical activity in the context of pulmonary rehabilitation. COPD. 2018;15(6):632–639. DOI:10.1080/15412555.2018.1563060
  • Hansen GM , Marott JL , Holtermann A , et al. Midlife cardiorespiratory fitness and the long-term risk of chronic obstructive pulmonary disease. Thorax. 2019;74(9):843–848. DOI:10.1136/thoraxjnl-2018-212821
  • Barbarito N , De Mattia E . Obesity paradox in chronic obstructive pulmonary disease: A result of airflow obstruction over-grading? Respir Med. 2017;126:133DOI:10.1016/j.rmed.2016.08.012
  • Landbo C , Prescott E , Lange P , et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–1861. DOI:10.1164/ajrccm.160.6.9902115
  • Ray CS , Sue DY , Bray G , et al. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128(3):501–506. DOI:10.1164/arrd.1983.128.3.501
  • Cecere LM , Littman AJ , Slatore CG , et al. Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD. 2011;8(4):275–284. DOI:10.3109/15412555.2011.586660
  • Parameswaran K , Todd DC , Soth M . Altered respiratory physiology in obesity. Can Respir J. 2006;13(4):203–210. DOI:10.1155/2006/834786
  • Rutten EP , Calverley PM , Casaburi R , et al. Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes? Ann Nutr Metab. 2013;63(3):239–247. DOI:10.1159/000353211
  • Sun Y , Milne S , Jaw JE , et al. BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials. Respir Res. 2019;20(1):236. DOI:10.1186/s12931-019-1209-5
  • Watson L , Vonk JM , Lofdahl CG , et al. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med. 2006;100(4):746–753. DOI:10.1016/j.rmed.2005.08.004
  • Ramachandran K , McCusker C , Connors M , et al. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron Respir Dis. 2008;5(4):205–209. DOI:10.1177/1479972308096711
  • Sava F , Laviolette L , Bernard S , et al. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med. 2010;10(1):55. DOI:10.1186/1471-2466-10-55
  • Blum A , Simsolo C , Sirchan R , et al. Obesity paradox" in chronic obstructive pulmonary disease. Isr Med Assoc J. 2011;13(11):672–675.
  • Pellegrino R , Gobbi A , Antonelli A , et al. Ventilation heterogeneity in obesity. J Appl Physiol. (1985). 2014;116(9):1175–1181. DOI:10.1152/japplphysiol.01339.2013
  • O'Donnell DE , Laveneziana P . The clinical importance of dynamic lung hyperinflation in COPD. COPD. 2006;3(4):219–232. DOI:10.1080/15412550600977478
  • Carbone S , Lavie CJ , Arena R . Obesity and heart failure: focus on the obesity paradox. Mayo Clin Proc. 2017;92(2):266–279. DOI:10.1016/j.mayocp.2016.11.001
  • Gomez-Ambrosi J , Silva C , Galofre JC , et al. Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obesity (Silver Spring). 2011;19(7):1439–1444. DOI:10.1038/oby.2011.36
  • Kraemer WJ , Torine JC , Silvestre R , et al. Body size and composition of National Football League players. J Strength Cond Res. 2005;19(3):485–489. DOI:10.1519/18175.1
  • Pepper DJ , Sun J , Welsh J , et al. Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2016;20(1):181. DOI:10.1186/s13054-016-1360-z
  • Zhao Y , Li Z , Yang T , et al. Is body mass index associated with outcomes of mechanically ventilated adult patients in intensive critical units? A systematic review and meta-analysis. PLoS One. 2018;13(6):e0198669. DOI:10.1371/journal.pone.0198669
  • Lavie CJ , Mehra MR , Milani RV . Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J. 2005;26(1):5–7. DOI:10.1093/eurheartj/ehi055
  • McDonald MN , Wouters EFM , Rutten E , et al. It's more than low BMI: prevalence of cachexia and associated mortality in COPD. Respir Res. 2019;20(1):100. DOI:10.1186/s12931-019-1073-3
  • Shah T , Press VG , Huisingh-Scheetz M , et al. COPD readmissions: addressing COPD in the era of value-based health care. Chest. 2016;150(4):916–926. DOI:10.1016/j.chest.2016.05.002
  • Caleyachetty R , Thomas GN , Toulis KA , et al . Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol. 2017;70(12):1429–1437. DOI:10.1016/j.jacc.2017.07.763
  • August GP , Caprio S , Fennoy I , et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab. 2008;93(12):4576–4599. DOI:10.1210/jc.2007-2458
  • Kotsis V , Jordan J , Micic D , et al. Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment. J Hypertens. 2018;36(7):1427–1440. DOI:10.1097/HJH.0000000000001730
  • Pischon T , Boeing H , Hoffmann K , et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359(20):2105–2120. DOI:10.1056/NEJMoa0801891
  • Vestbo J , Prescott E , Almdal T , et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006;173(1):79–83. DOI:10.1164/rccm.200506-969OC
  • Lainscak M , von Haehling S , Doehner W , et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle. 2011;2(2):81–86. DOI:10.1007/s13539-011-0023-9
  • Houchen-Wolloff L , Williams JE , Green RH , et al. Survival following pulmonary rehabilitation in patients with COPD: the effect of program completion and change in incremental shuttle walking test distance. COPD. 2017;13:37–44. DOI:10.2147/COPD.S143101
  • Putman RK , Hatabu H , Araki T , et al. Association between interstitial lung abnormalities and all-cause mortality. JAMA. 2016;315(7):672–681. DOI:10.1001/jama.2016.0518
  • Stanchina ML , Welicky LM , Donat W , et al. Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome. J Clin Sleep Med. 2013;09(08):767–772. DOI:10.5664/jcsm.2916

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.